BACKGROUND: Mucosal immunity induced by oral poliovirus vaccine (OPV) is imperfect and potentially allows immunized individuals to participate in asymptomatic wild-type poliovirus transmission in settings with efficient fecal-oral transmission of infection. METHODS: We examined the extent of asymptomatic wild-type poliovirus transmission in India by measuring the prevalence of virus in stool samples obtained from 14,005 healthy children who were in contact with 2761 individuals with suspected poliomyelitis reported during the period 2003-2008. RESULTS: Wild-type poliovirus serotypes 1 and 3 were isolated from the stool samples of 103 (0.74%) and 104 (0.74%) healthy contacts, respectively. Among contacts of individuals with laboratory-confirmed poliomyelitis, 27 (12.7%) of 213 and 29 (13.9%) of 209 had serotypes 1 and 3, respectively, isolated from their stool samples. The odds ratio of excreting serotype 1 wild-type poliovirus was 0.13 (95% confidence interval, 0.02-0.87) among healthy children reporting 6 doses of OPV, compared with children reporting 0-2 doses. However, two-thirds of healthy children who excreted this virus reported >or=6 doses, and the prevalence of this virus did not decrease with age over the sampled range. CONCLUSIONS: Although OPV is protective against infection with poliovirus, the majority of healthy contacts who excreted wild-type poliovirus were well vaccinated. This is consistent with a potential role for OPV-vaccinated children in continued wild-type poliovirus transmission and requires further study.
BACKGROUND: Mucosal immunity induced by oral poliovirus vaccine (OPV) is imperfect and potentially allows immunized individuals to participate in asymptomatic wild-type poliovirus transmission in settings with efficient fecal-oral transmission of infection. METHODS: We examined the extent of asymptomatic wild-type poliovirus transmission in India by measuring the prevalence of virus in stool samples obtained from 14,005 healthy children who were in contact with 2761 individuals with suspected poliomyelitis reported during the period 2003-2008. RESULTS: Wild-type poliovirus serotypes 1 and 3 were isolated from the stool samples of 103 (0.74%) and 104 (0.74%) healthy contacts, respectively. Among contacts of individuals with laboratory-confirmed poliomyelitis, 27 (12.7%) of 213 and 29 (13.9%) of 209 had serotypes 1 and 3, respectively, isolated from their stool samples. The odds ratio of excreting serotype 1 wild-type poliovirus was 0.13 (95% confidence interval, 0.02-0.87) among healthy children reporting 6 doses of OPV, compared with children reporting 0-2 doses. However, two-thirds of healthy children who excreted this virus reported >or=6 doses, and the prevalence of this virus did not decrease with age over the sampled range. CONCLUSIONS: Although OPV is protective against infection with poliovirus, the majority of healthy contacts who excreted wild-type poliovirus were well vaccinated. This is consistent with a potential role for OPV-vaccinated children in continued wild-type poliovirus transmission and requires further study.
Authors: Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi Journal: Risk Anal Date: 2013-03-05 Impact factor: 4.000
Authors: Bryan T Mayer; Joseph N S Eisenberg; Christopher J Henry; M Gabriela M Gomes; Edward L Ionides; James S Koopman Journal: Am J Epidemiol Date: 2013-04-16 Impact factor: 4.897
Authors: Benjamin P Steil; Patricia Jorquera; Janny Westdijk; Wilfried A M Bakker; Robert E Johnston; Mario Barro Journal: Vaccine Date: 2013-12-13 Impact factor: 3.641
Authors: Rashidul Haque; Cynthia Snider; Yue Liu; Jennie Z Ma; Lei Liu; Uma Nayak; Josyf C Mychaleckyj; Poonum Korpe; Dinesh Mondal; Mamun Kabir; Masud Alam; Mark Pallansch; M Steven Oberste; William Weldon; Beth D Kirkpatrick; William A Petri Journal: Vaccine Date: 2013-12-02 Impact factor: 3.641
Authors: Kathleen M O'Reilly; Claire Chauvin; R Bruce Aylward; Chris Maher; Sam Okiror; Chris Wolff; Deo Nshmirimana; Christl A Donnelly; Nicholas C Grassly Journal: PLoS Med Date: 2011-10-18 Impact factor: 11.069
Authors: Faisal M Shuaibu; Gerida Birukila; Samuel Usman; Ado Mohammed; Michael Galway; Melissa Corkum; Eunice Damisa; Pascal Mkanda; Frank Mahoney; Gatei Wa Nganda; John Vertefeuille; Anna Chavez; Sule Meleh; Richard Banda; Almai Some; Hyelni Mshelia; Al-Umra Umar; Ogu Enemaku; Andrew Etsano Journal: J Public Health Policy Date: 2015-11-05 Impact factor: 2.222